Hospital Acquired Pneumonia Prevention (HAPPEN) Study: Statistical Analysis Plan
White, N. M.; Cheng, A.; Stewardson, A.; Russo, P.; Mitchell, B.
Show abstract
The Hospital-acquired Pneumonia Prevention (HAPPEN) study is a multi-site trial evaluating the clinical effectiveness of improving oral care among adult patients to reduce the incidence of non-ventilator, hospital-acquired pneumonia (HAP). The HAPPEN study design is a stepped-wedge cluster randomised trial across three public hospitals in Australia. This document is the Statistical Analysis Plan for evaluating primary and secondary effectiveness outcomes. The trial was preregistered on the Australian and New Zealand Clinical Trials registry (ACTRN12624000187549) and is funded by the Medical Research Future Fund (MRF2022645). A copy of the study protocol and a signed version of the Statistical Analysis Plan are available on request from the corresponding author (BM).
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Statistical Analysis Plan for the Stepped-wedge Cluster Randomized Controlled Trial of Electronic Early Notification of Sepsis in Hospitalized Ward Patients (SCREEN): a study protocol for a stepped-wedge cluster randomized controlled trial 95%
- Decision support system to evaluate VENTilation in the Acute Respiratory Distress Syndrome (DeVENT study) – Trial Protocol 93%
- Electronic early notification of sepsis in hospitalized ward patients: a study protocol for a stepped-wedge cluster randomized controlled trial 93%
Similar papers in this journal
- Helmet noninvasive ventilation for COVID-19 patients (Helmet-COVID): study protocol for a multicenter randomized controlled trial 93%
- Criteria to Achieve Safe Antimicrobial Intravenous-to-Oral Switch in Hospitalised Adult Populations: A Systematic Rapid Review 92%
- A rapid systematic review of measures to protect older people in long term care facilities from COVID-19 92%
Similar papers in this journal
- Investigating the use of a one-page infographic to improve recruitment and retention to the BASIL+ Randomised Controlled Trial: A Study Within a Trial (SWAT) 94%
- STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol 94%
- Doxycycline for the prevention of progression of COVID-19 to severe disease requiring intensive care unit (ICU) admission: a randomized, controlled, open-label, parallel group trial (DOXPREVENT.ICU) 93%
Similar papers in this journal
- Evidence-Based, Cost-Effective Interventions To Suppress The COVID-19 Pandemic: A Systematic Review 91%
- Adverse events of iron and/or erythropoiesis-stimulating agent therapy in preoperatively anaemic elective surgery patients: a systematic review 90%
- Preventing respiratory illness in older adults aged 60 years and above living in long-term care: A rapid overview of reviews 90%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.